Back to Agenda
ELECTRONIC TRIAL MASTER FILE (eTMF) LEVERAGING
Session Chair(s)
Karen Roy, MPharm
Chief Strategy Officer
Phlexglobal, United Kingdom
Recently, a few organizations are beginning to view TMF more strategically and dynamically. Companies should realize that there is a wealth of information representing years of clinical trial experience that is very valuable from a KM perspective.
Learning Objective : Participants will walk away with a sense that the TMF is more than a collection of clinical trial documentation. Properly managed and harnessed, it can be a gold-mine for strategic knowledge management (lessons learned, resource data, critical decisions) that can aid an organization in making critical decisions that drive the business.
Speaker(s)
Rohin Rajan
Deloitte Consulting, United States
Management Consultant - Life Sciences Strategy
TMF as a Knowledge Management Catalyst
Keith D. Davis, MBA
Biogen Idec, United States
Global Director & Head, R&D Records Management
21st Century TMF -Insights and Trends
Paul Fenton, MBA
Montrium, Canada
CEO
Panel Discussion
Lisa Mulcahy
Mulcahy Consulting, LLC, United States
Owner, Principal Consultant
Michael Sauter
United States
Senior Director, Global Regulatory Operations
Martin David Thorley
Pfizer Ltd, United Kingdom
Associate Director - Senior Information Manager
Have an account?